Beta-Nicotinamide Adenine Dinucleotide Sodium Salt(CAS: 20111-18-6)

Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) is subject to various regulatory guidelines. It falls under the classification of food additives and pharmaceuticals. In the US, it is regulated by the FDA for use in food and pharmaceuticals, while the EPA oversees its environmental impact. In the EU, it is regulated under REACH, which includes risk assessment and registration requirements for chemicals.

Alternatives to Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) in synthesis include using the free base form or other nucleotide analogs. Isomers or structural analogs like deoxyadenosine monophosphate sodium salt can also be used as substitutes, depending on the specific application in biochemistry or pharmacology.

The market trend for Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) is showing steady growth, particularly in the pharmaceutical and biotech sectors. Research is focusing on its role in cellular metabolism, aging, and potential therapeutic applications. Recent studies are exploring its use in developing treatments for neurological disorders and cancer.

Waste containing Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) should be handled with care to ensure environmental safety. Collect waste in appropriate containers, and follow local disposal regulations. It is recommended to incinerate or dispose of the waste through a professional hazardous waste management service. Always ensure proper personal protective equipment is used and follow local environmental protection guidelines.